Respiratory syncytial virus, or RSV, is a lung infection that’s highly contagious. But a vaccine recently approved by the FDA will soon be available for adults 60 or older. Here’s what to expect.
Related Posts
Technical Analysis: 4 Stocks with signs of death crossovers to keep an eye on
HDFC Bank & 3 other fundamentally strong stocks trading above 200 DMA to keep an eye on
Falling Channel Breakout: Multibagger NBFC Stock Shows Bullish Momentum on Daily Chart
4 Fundamentally strong stocks to buy for an upside potential of up to 36%; Do you hold any?
